Birmingham is suing drug manufacturers and health companies, alleging they worked together to establish an “insulin pricing scheme” and inflate the cost of life-saving medicine.
Updated: Jan. 23, 2025, 12:33 p.m.
In 2018, the price per vial of insulin in the United States was $98.70, compared to $9 in France, $12 in Canada, and less than $7 in Australia. The lawsuit, filed Jan.14, is part of national litigation on insulin pricing. Over 200 lawsuits have been filed since 2023 seeking accountability for inflated drug prices.
Birmingham estimated in the complaint that it’s responsible for paying for prescription plans for upwards of 7,000 employees, spending between $500,000 to $1 million a year on diabetes medications for its beneficiaries. Those numbers don’t include the additional cost of providing medications to people in city-run facilities like jails.
The companies allegedly engineered price increases on insulin through an “opaque, conspiratorial kickback scheme that has exponentially increased their profits at the expense of payors,” according toEven though drug companies Eli Lilly, Novo Nordisk and Sanofi announced they would cap insulin prices at $35 a month in 2023, Birmingham said the price cuts were limited and “do not mitigate damages already incurred.
@River-State @Contributor @Exvideo
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
‘How is my insulin going to stay cold’ some residents on edge as power shutoffs loomAustin Grabish traded in winter boots for a surfboard. He joined the ABC 10News team as a reporter in January 2023 after reporting for CBC, Canada's national public broadcaster, for six years.
Read more »
How Insulin Affects Alzheimer's + 2 Diets That May Lower The RiskThis article investigates the link between insulin resistance and Alzheimer's disease. It explains how insulin resistance can impact brain health and memory function, and highlights two dietary approaches – intermittent fasting and the ketogenic diet – that may help lower insulin levels and reduce the risk of developing Alzheimer's.
Read more »
Columbus Sues Drug Companies for Inflated Insulin PricesThe City of Columbus has filed a lawsuit against several pharmaceutical companies and pharmacy benefit managers (PBMs) for allegedly inflating insulin prices for decades, resulting in millions of dollars in excessive costs for taxpayers. The lawsuit seeks to recover these funds and hold accountable those responsible for this alleged unethical pricing scheme.
Read more »
Columbus sues drug companies over insulin price gougingColumbus City Attorney Zach Klein announced that the city has filed a lawsuit against several drug companies and pharmacy benefit managers...
Read more »
California's Ambitious Insulin Plan Faces Delays, Unlikely to Reach Market for YearsGovernor Newsom's plan to produce affordable insulin for Californians has been significantly delayed. The project, intended to address the high cost of diabetes medication, is facing hurdles in clinical trials and FDA approval. Experts predict a wait of several years before the insulin becomes available.
Read more »
Working Out At This Time Of Day Could Reduce Insulin Resistance Up To 25%Clear your schedule this afternoon; it's time to work out!
Read more »